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Electronic Health Records As a Platform for Audiological 
Research: Data Validity, Patient Characteristics, and 
Hearing-Aid Use Persistence Among 731,213 U.S. Veterans
Gabrielle H. Saunders,1,2 Lauren K. Dillard,2,3 Oliver Zobay,2,4 John B. Cannon,2 and Graham Naylor4 
Objectives: This article presents a summary of audiological, general 
health, and hearing aid (HA) outcome data in a large sample of U.S. 
Veterans receiving HAs. The current article also provides the founda-
tion for a series of papers that will explore relationships between a wide 
range of factors and HA outcomes.
Design: The patient sample is all (n = 731,213) patients for whom HAs 
were ordered between April 2012 and October 2014 through the U.S. 
Veterans Health Administration Remote Order Entry System. For these 
patients, Veterans Affairs electronic health records (EHRs) stored in vari-
ous databases provided data on demographics, received diagnostic and 
procedure codes (2007 to 2017), audiometry, self-reported outcomes 
up to 6 months postfitting, and HA battery orders (to 2017). Data clean-
ing and preparation was carried out and is discussed with reference to 
insights that provide potential value to other researchers pursuing simi-
lar studies. HA battery order data over time was used to derive a mea-
sure of long-term HA use persistence. Descriptive statistics were used 
to characterize the sample, comparative analyses against other data sup-
ported basic validity assessment, and bivariate analyses probed novel 
associations between patient characteristics and HA use persistence at 
2 years postfitting.
Results: Following extensive cleaning and data preparation, the data 
show plausible characteristics on diverse metrics and exhibit adequate 
validity based on comparisons with other published data. Further, rates 
of HA use persistence are favorable when compared against therapy per-
sistence data for other major chronic conditions. The data also show that 
the presence of certain comorbid conditions (Parkinson’s disease, dia-
betes, arthritis, and visual impairment) are associated with significantly 
lower HA use persistence, as are prior inpatient admissions (especially 
among new HA recipients), and that increasing levels of multimorbidity, 
in general, are associated with decreasing HA use persistence. This is all 
despite the fact that deriving relevant audiological care-process variables 
from the available records was not straightforward, especially concern-
ing the definition of the date of HA fitting, and the use of battery ordering 
data to determine long-term HA use persistence.
Conclusions: We have shown that utilizing EHRs in audiology has the 
potential to provide novel insights into clinical practice patterns, audio-
logic outcomes, and relations between factors pertaining to hearing and 
to other health conditions in clinical populations, despite the potential 
pitfalls regarding the lack of control over the variables available and 
limitations on how the data are entered. We thus conclude that research 
using EHRs has the potential to be an integral supplement to population-
based and epidemiologic research in the field of audiology.
Key words: Audiology, Comorbidity, Electronic health records, Hearing 
aid outcome, Hearing aid use, Hearing aids, Hearing health care, 
Multimorbidity, Persistence, Veterans Administration, Veterans Health 
Administration.
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INTRODUCTION
Electronic health records (EHRs) have been used by many 
medical professions to understand trends in health care provi-
sion, find connections between comorbid conditions, and deter-
mine factors influencing treatment outcomes (Casey et al. 2016). 
Typically, EHR-based studies leverage large sample sizes and 
diversity of data domains to illuminate relations and processes, 
which would be very costly to study through ab initio research 
designs. In audiology, few large-scale studies using EHRs exist. 
Some examples follow. Zapala et al. (2010) reviewed 1550 
Medicare EHRs and determined that self-referral to audiology 
services (as opposed to via otology) would not pose a safety 
risk. Wilson & McArdle (2013) examined clinical audiometric 
data of almost 750,000 Veterans from the U.S. Department of 
Veterans Affairs (VA) audiological data repository to character-
ize notched audiometric configurations. Their findings presented 
a complex picture about the presence, depth, and symmetry of 
notched audiograms. Billings et al. (2018) examined data from 
the same source to determine the prevalence of normal hearing 
thresholds among 2.3 million Veterans seeking hearing health 
care within the VA health care system and the prevalence of 
abnormal clinical audiology test results in these Veterans. They 
determined that 10% of Veterans seeking hearing healthcare 
from the VA had normal pure-tone hearing thresholds and that 
41% of these had some other audiological abnormality. Using 
data from a wider subset of the VA clinical data repository, Swan 
et al. (2017) described the prevalence of hearing loss and tinnitus 
in a cohort of 500,000 Iraq and Afghanistan Veterans with com-
mon post-deployment conditions, such as traumatic brain injury, 
post-traumatic stress disorder, and vertigo/dizziness. They used 
their findings to recommend that post-deployment conditions 
should be carefully considered in the planning of clinical care 
and beyond. Singh & Launer (2016) examined almost 61,000 
patient records from a chain of private audiology clinics in the 
United Kingdom to determine whether hearing aid (HA) adop-
tion among patients attending a first-time audiology visit with a 
significant other (SO) differed from that for patients attending 
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the visit alone. They found greater HA adoption among those 
attending the visit with a SO, particularly for individuals with 
a mild hearing loss. They concluded that audiologists should 
encourage SOs to participate in the audiologic rehabilitation 
process. In Sweden, a unique system has been established to 
collect clinical and outcome data from audiology clinics and 
their patients across the country. This system combines fea-
tures of clinical EHR and controlled outcomes research and 
has, for example, been able to show that self-reported outcomes 
are likely to vary more as a function of which clinic the patient 
visits than as a function of unilateral versus bilateral HA fitting 
(Arlinger et al. 2017).
Using clinical databases to conduct research has inherent 
limitations associated with the fact that the data are not col-
lected for the purpose of research and thus are not always col-
lected and entered in a controlled manner. In addition, verifying 
data validity is a major issue that demands substantial care and 
effort. Thus, before concluding that novel associations found in 
an EHR dataset reflect real effects, it is important to establish 
confidence in the dataset. See Dillard et al. (2020) for additional 
discussion of issues that can arise when using and interpreting 
data from EHR datasets.
This article describes the first stage of a project which 
exploits a large set of clinical data comprised of patients 
who have been fitted with HAs through the Veterans Health 
Administration (VHA). The data include a diverse array of 
diagnostic, care process, and outcome variables. Ultimately, 
we aim to elucidate clinically significant connections between 
these variables, which may have previously gone unnoticed or 
been inaccessible, and to verify other associations that have 
been indicated in smaller data samples.
We envisage that our findings can be used to provide a basis 
for future research on predictors of hearing care outcomes and 
potential ways in which hearing loss influences general health 
and vice versa, to develop practice recommendations with a 
view to development of more time and cost-effective clinical 
care pathways, and to illuminate potential issues and solutions 
specific to the exploitation of service-wide datasets in audiology.
The aims of this article are to provide a general description 
of the provenance of the dataset, to substantiate the overall valid-
ity and plausibility of its primary characteristics, to provide 
evidence that EHRs can be used for research in audiology, and 
to describe the platform for our future work with EHRs. The 
article is organized as follows. First, we describe the sources of 
the data, and the data cleaning and preparation processes, which 
led to the final dataset for analysis. Second, to provide a common 
background of data for subsequent papers, we describe the study 
sample by using summary statistics and descriptive analyses. 
Third, we provide some analyses examining internal and exter-
nal validity and discuss the plausibility of the basic relationships 
found. Finally, we present some bivariate associations between 
hearing-related and health-related variables. These demonstrate 
the potential of such datasets for revealing previously unseen 
substantive associations. In future publications, we will report 
in depth on distinct relations among the data and interpret their 
significance for research and clinical practice.
MATERIALS AND METHODS
This work was approved by the Institutional Review Board 
and the Research and Development Committee at the VA 
Portland Health Care System (Study #03566), as well as from 
Data Access Request Tracker (tracking number 2014-11-066-
D-A04) and VA Patient Care Services (PCS).
Relevant Aspects of VA Audiological Services
The service delivery context within which these VA data 
have arisen is necessary for understanding data structures, 
determining validity, and interpreting results; therefore, it is 
described here.
VA Healthcare System • The VHA is the largest integrated 
health care system in the United States. It provides care to over 
9 million Veterans each year at over 1,200 health care facilities 
(https://www.va.gov/health/aboutVHA.asp). All Veterans who 
have served in the active military and were not dishonorably sep-
arated, as well as members of the Reserve forces or U.S. National 
Guard who successfully completed the period of Active-Duty to 
which they were called by federal order, qualify for VA health 
care benefits. Benefits include audiological care and HA pro-
vision. Since 1994, the VHA has used an EHR system, known 
as Veterans Health Information Systems and Technology 
Architecture, to store clinical and administrative data for patient 
records. The data here originate from the Veterans Health 
Information Systems and Technology Architecture system.
Audiology Services • Audiology services are provided at more 
than 500 VA sites of care to hundreds of thousands of patients 
annually (Veterans Health Administration 2018). Audiology 
appointments can be scheduled either following a referral from 
a VA medical professional or (since 2016) through self-referral. 
Once registered with the audiology service, individuals receive 
a hearing evaluation. If HAs are considered appropriate, they 
will be ordered, and a fitting appointment will be scheduled. 
Following the fitting, some clinics automatically schedule a HA 
follow-up visit, while other clinics require patients to initiate 
one if desired. This is dependent upon local policy.
If clinically indicated (VHA Directive 2008-070), HAs, 
related accessories, and batteries are provided to Veterans 
free of cost through the VA. Veterans receive a bilateral fitting 
unless patient preference or the hearing loss indicates other-
wise. Veterans order a new supply of batteries when needed 
through the Denver Acquisition and Logistics Center. Batteries 
are shipped in quantities sufficient for 6 months of full-time HA 
use. This is determined according to the HA model in question 
and whether the Veteran has been fitted bilaterally or unilaterally.
Audiometry • In addition to saving audiometric data in local 
electronic patient records, audiologists are encouraged to enter 
these data using the Quality Audiology and Speech Analysis 
and Reporting system into a central database known as the 
Hearing Loss Repository.
Self-Reported Outcome: International Outcome Inventory 
for HA • VA audiologists are encouraged to administer a vali-
dated HA outcome questionnaire after each HA fitting to docu-
ment the efficacy of treatment (Department of Veterans Affairs 
2011). In 2011, the VA recommended use of the International 
Outcome Inventory for HAs (IOI-HAs; Cox et al. 2003) as the 
preferred HA outcome measure. The IOI-HA assesses HA out-
come over the past 2 weeks on seven dimensions (use, satisfac-
tion, benefit, residual activity limitations, residual participation 
restrictions, impact on others, quality of life) using a single item 
for each. The VA IOI-HA has an extra (8th) item for self-rated 
(unaided) hearing difficulty. A template for entering IOI-HA 
responses is available to audiologists within the Remote Order 
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Entry System (ROES). The VA-recommended mode of admin-
istration for the IOI-HA is to mail the questionnaire to patients 
30 days after their HA fitting, with a return envelope.
Data Sources and Analysis Environment
We obtained access to the data through two sources: (1) PCS 
and (2) the Corporate Data Warehouse (CDW). PCS provided 
access to data from ROES for information relating to device 
orders, battery orders and the IOI-HA, and to data from the 
Hearing Loss Repository relating to audiometry. The CDW pro-
vided access to demographic data and diagnostic and procedural 
codes. See Figure 1 for details. Every individual in the system 
has a unique identifier that is common across the data sources 
and that was used to link data extracted from each database.
All analyses were carried out within the VA Informatics 
and Computing Infrastructure workspace, a secure high-per-
formance data processing platform for research. The CDW 
extract was provided in the form of a relational database that 
was accessed through Microsoft SQL Server Studio. Tables of 
interest were then imported into R statistical software (R Core 
Team 2020), where they were combined with the PCS dataset 
(provided as a text file) for analysis.
Patient Sample and Data Extracts
Our aim was to extract data for all patients who had received 
a HA from VHA for the 31-month period from April 1, 2012, to 
October 31, 2014 (the “study time window”). However, because 
there was not a single specific Current Procedural Terminology 
(CPT) or Healthcare Common Procedure Coding System 
(HCPCS) procedural code for a HA fitting, it was necessary to 
extract data using a set of codes that clinical experience indi-
cated were typically used to designate a HA fitting. Thirty-three 
such codes were identified (see File 1 in Supplemental Digital 
Content 1, http://links.lww.com/EANDH/A732 for details). Data 
were then extracted for any patient who had at least one of these 
33 procedural codes in their outpatient CDW records within the 
study time window. Data from individuals in this dataset who did 
not have a HA order in ROES were discarded, leaving 731,213 
patients who had a HA order and a procedural code indicat-
ing a HA fitting. Table 1 summarizes the variables extracted for 
these 731,213 individuals, including the date range, which var-
ies depending on the type of data.
Data Cleaning and Preparation
Since the data were extracted from clinical databases, exten-
sive data cleaning and preparation was required before conduct-
ing any analyses. The following section describes processes 
undertaken to clean and prepare the data.
Demographic Data • In the CDW database, patients who 
receive care at more than one VA station have separate demo-
graphic records at each site; thus, it was necessary to identify, 
verify consistency, and merge these records. In total, 731,209 
patients had a demographic record that included date of birth 
and gender, and in 99.96% of all cases, the information regard-
ing gender and dates of birth and death was identical across 
records. There were 313 patients with inconsistent data for 
whom we used the most frequent field value across a person’s 
records in all analyses. Forty-two patients had a record in which 
the date of birth or death appeared implausible (e.g., date of 
death preceded the HA order). Data from these patients were 
excluded from analyses requiring age or survival information.
Fig. 1. Sources of study data. CDW indicates Corporate Data Warehouse; CPRS, Computerized Patient Record System; DALC, Denver Acquisition and Logistics 
Center; EMR, electronic medical record; HLR, Hearing Loss Repository; IOI-HA, International Outcome Inventory for Hearing Aids; PCS, Patient Care Services; 
QUASAR, Quality Audiology and Speech Analysis and Reporting; ROES, Remote Order Entry System; VINCI, Veterans Affairs Informatics and Computing 
Infrastructure; VistA, Veterans Health Information Systems and Technology Architecture.
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Demographic variables were used as entered in the dataset; 
thus, no data preparation took place.
Data from the 20.8% of patients who died between their first 
HA order and the end of the study period (December 31, 2017) 
were included or excluded in analyses depending on the time 
period in question. For example, to compute 2-year HA per-
sistence rates, patients who died within 2 years after their HA 
fitting were excluded. In contrast, no patients were excluded for 
the calculation of patient demographics because all were alive 
at the time these data were extracted.
Hearing Care Processes • It was assumed that all International 
Classification of Diseases (ICD) and procedural codes entered 
into a patient’s record represented the occurrence of a valid clin-
ical encounter; thus, no data cleaning was required here.
To reconstruct a patient’s VA-provided hearing-care history 
within the time frame for which data were extracted, we assem-
bled a comprehensive list of ICD and procedural codes related 
to hearing care as described later and then extracted all records 
from the outpatient diagnosis and procedure tables that had any 
of these codes. All records with the same date were assumed to 
represent a single hearing care appointment during which mul-
tiple procedures had taken place.
Identifying all codes pertaining to hearing care (addi-
tional to the 33 deemed to indicate a HA fitting) was com-
plex because there are over 60,000 ICD-9, ICD-10, and CPT 
procedural codes available in the VA system. To identify the 
relevant codes, we selected 100,000 random patients from our 
sample. For each patient, up to five dates with records of audi-
ometry and/or HA orders in the PCS dataset were identified. 
For each combination of patient and date, all corresponding 
records of outpatient diagnoses and procedures were docu-
mented. Further codes were then added to the list following 
examination of the corresponding sections of the coding sys-
tems. This resulted in 158 procedural codes, 53 ICD-9 codes, 
and 101 ICD-10 codes, which we deemed to be “related to 
hearing care” (see File 2 in Supplemental Digital Content 2, 
http://links.lww.com/EANDH/A733). A hearing-care event 
was assumed to have taken place on any date on which at least 
one of these codes was present.
As noted earlier, there was no single procedural code for 
a HA fitting in the dataset. This was problematic for analyses 
requiring reference to the date of a HA fitting. We thus decided 
to designate the date of the first HA battery order as the “HA 
fitting date” as long it was no more than 180 days after the HA 
order. We consider this valid because almost all (98.6%) HA 
orders were followed by a battery order within 180 days and, for 
62.0% of patients, the first battery order date coincided with the 
first hearing-care event after the HA order.
Audiometry • The audiometric data required extensive 
cleaning because there were both non-numeric values that 
could not be analyzed and other anomalies in the data. In 
File 3 (Supplemental Digital Content 3, http://links.lww.com/
EANDH/A734), we describe each feature of the data that 
required cleaning and provide an explanation for why the anom-
aly arose, the solution we applied to manage the problem, and 
the percentage of patients with affected data. Problems encoun-
tered included the need to replace non-numeric indicators for 
thresholds above the upper limit of the audiometer with a value 
of 120 dB as recommended by Rahne et al. (2016) (23.6% of 
audiograms affected), and treating ambiguous non-numeric 
entries and values not divisible by 5 as missing (0.86% of audio-
grams affected). We acknowledge that both of these problems 
could have been managed in other ways, such as by designating 
a value of 5 dB greater than the frequency-specific upper limit 
of the audiometer, and/or by imputing missing values based on 
known values, and that the choice of approach will influence 
the outcome to some extent. However, with our large dataset 
and relatively few missing values, we believe the impact of our 
using one approach over another is minimal.
We considered an air conduction audiogram to be valid for 
use in analyses if, after cleaning, it had numerical threshold val-
ues (including 120 dB) at frequencies 0.5, 1.0, 2.0, and 4.0 kHz 
for both left and right ears. From these values, we computed 
left, right, and bilateral four-frequency pure-tone averages 
TABLE 1. Data tables and variables extracted from databases
Data table in dataset Records comprised of Source Date range
Demographics Patient ID, date of birth, date of death, gender CDW January 2007 to  
December 2017
Outpatient diagnoses Patient ID, ICD code, date and time diagnostic code assigned CDW January 2007 to  
December 2017
Outpatient procedures Patient ID, CPT/HCPCS code, date and time procedural code assigned CDW January 2007 to  
December 2017
Inpatient stays Patient ID, admission and discharge dates, primary and secondary  
diagnoses (up to 25)
CDW January 2007 to  
December 2017
Audiometry Patient ID, date of examination, AC thresholds at octave and interoctave  
frequencies from 250 to 8000 Hz, BC thresholds at octave and interoctave  
frequencies from 250 to 4000 Hz
HLR April 2012 to  
October 2014
Hearing aid orders Patient ID, date of order, user type (new/experienced*); hearing aid style  
(BTE/ITE†/RIC); laterality (left/right/both)
ROES April 2012 to  
October 2014
Battery orders Patient ID, date of order ROES April 2012 to  
December 2017
IOI-HA Patient ID, date of completion specified by patient, date of entry into ROES,  
individual item scores
ROES April 2012 to  
March 2015
*Assigned by system based on the presence/absence of a prior hearing aid order in ROES.
†ITE includes all custom hearing aid styles.
AC, air conduction; BC, bone conduction; BTE, behind the ear; CDW, Corporate Data Warehouse; CPT, Current Procedural Terminology; HCPCS, Healthcare Common Procedure Coding 
System; HLR, Hearing Loss Repository; ICD, International Classification of Diseases; ID, identifier; IOI-HA, International Outcome Inventory for Hearing Aids; ITE, in the ear; RIC, receiver in 
the canal; ROES, Remote Order Entry System.
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(4F-PTAs). To examine differences between left and right ears, 
we computed a variable to designate a clinically relevant asym-
metry—defined as an absolute difference between the left and 
right ear 4F-PTA of ≥15 dB HL.
For simplicity in this initial article, we chose not to analyze 
bone conduction thresholds. Bone conduction thresholds will 
be addressed in future work examining associations between 
hearing conditions and other data.
Thirteen percent (n = 94,690) of patients had multiple valid 
audiograms within the 31-month study time window. These 
were averaged into a single 4F-PTA for analyses.
HA and Battery Orders • Records for HA orders and battery 
orders did not contain any obvious outliers or invalid entries, 
and missing data were not detectable; thus, these data did not 
require any cleaning.
Note that the ROES dataset included a variable classifying 
each given patient as either a new HA recipient or an experi-
enced HA user, based on whether or not they had a prior HA 
order in ROES. We acknowledge that a small number of patients 
classified as new recipients had possibly previously used HAs 
that had been obtained from a source other than the VA. It was 
not possible to crosscheck this information using CDW data; 
thus, the classifications provided by the system were accepted 
as found. No data preparation was necessary.
Objective Measure of Long-Term HA Use (Persistence) • A 
unique feature of this study is the use of battery ordering his-
tory to provide a proxy measure of continued long-term HA 
use. Specifically, we considered battery orders to be analogous 
to prescription refills, which are often used to indirectly quan-
tify adherence to medications. Battery order data are appropri-
ate because 99.8% of all patients have battery order data after 
their first HA order.
We evaluated a variety of measures commonly used to quan-
tify treatment adherence: (1) Compliance—which refers to the 
act of conforming to the recommendations made by the provider 
with respect to timing, dosage, and frequency of medication 
taking; (2) Persistence—which can be defined as the duration 
of time from initiation to discontinuation of therapy or the pro-
portion of patients still continuing therapy at a given time after 
initiation, and (3) Medication Possession Ratio—defined as the 
number of doses dispensed in relation to the dispensing period, 
or more specifically, the ratio of the number of days for which 
a patient has medication on hand divided by the total number 
of days a patient was observed (Hess et al. 2006; Cramer et al. 
2008). We chose to use persistence as our measure because it 
provides a straightforward description of the whole sample at 
a given time postfitting without being complicated by differing 
recommendations from individual audiologists regarding daily 
HA use (analogous to dose).
Details of the method used to compute persistence are 
described in File 4 (Supplemental Digital Content 4, http://links.
lww.com/EANDH/A735). In summary, we consider “Dose” 
(D
dose
) to be the 6-month supply of HA batteries, the “acceptable 
gap” (G
acc
) in medication use (i.e., HA use) to be 12 months, and 









 is the time of the most recent 




 are as defined earlier. 
HA use persistence at time T is then simply the proportion of 
the total patient sample who are persistent at time T.
An unavoidable limitation of using battery orders to com-
pute persistence is that the prescribed dose period is relatively 
long (6 months). Thus, the minimum postfitting time T for 
which persistence can be <1 is 18 months. In this article, HA 
use persistence is always reported for T = 24 months postfitting.
Self-Reported Outcome: IOI-HA • The battery order-based 
persistence measure described earlier precludes analyses that 
might be informative about HA usage trends in the short-term 
postfitting. However, the overall dataset includes self-reported 
HA usage in the months following fitting.
There are no missing data or values outside of expected lim-
its for the IOI-HA responses because the ROES system only 
allows entry of complete questionnaires, with entered values 
being constrained to integers 1 through 5.
The dataset does not explicitly link a given IOI-HA survey 
to a specific HA order, so we assumed that each survey reflected 
the  outcome from the most recent preceding HA order for a 
given patient. The assignment of IOI-HA data to HA orders was 
thus unambiguous for the 99.5% of patients with a single survey 
(N = 157,967). There were, however, 717 patients (0.5%) with 
two sets of IOI-HA data, 689 of whom had two HA orders in the 
study time window. For the remaining 28 patients, both sets of 
IOI-HA data were preceded by the same HA order. For simplic-
ity of interpretation, the IOI-HA data for these 28 patients were 
excluded from further analysis.
VA policy states that IOI-HAs should be returned between 14 
and 180 days after a HA fitting. Only IOI-HAs returned within 
this time frame were used in analyses, resulting in a total of 
147,285 questionnaires pertaining to 146,699 different patients.
A total IOI-HA score was computed by summing scores 
from items 1 to 7. Question 8 (reported unaided hearing dif-
ficulty) is analyzed separately. We acknowledge that the seven 
items in the IOI-HA are separate Likert scales rather than a sin-
gle interval scale. However, for purposes here, we have analyzed 
the questionnaire as a single continuous interval scale because it 
facilitates comparison with results from other studies that have 
done likewise. Further, according to some, this approach is a 
pragmatic solution to a statistical controversy (see Knapp 1990 
for further discussion).
Disease Burden • The dataset included a total of 215,342,996 
outpatient ICD codes and 288,683,650 outpatient procedural 
codes, as well as 7,152,903 inpatient ICD codes and 1,252,359 
inpatient procedural codes.
For each patient, diagnostic (ICD) and procedural (CPT/
HCPCS) codes that had been assigned between January 2007 
and December 2017 were extracted from the CDW database, 
along with time and date stamps. When deriving indices of 
general disease burden (see later), data concerning conditions 
not directly related to hearing have been taken as found, and no 
cleaning was conducted.
A major complication arose in the dataset because the ICD-9 
code set was replaced by ICD-10 on October 1, 2015. Therefore, 
pre-HA order diagnoses are recorded with ICD-9 codes, while 
postorder diagnoses are recorded with both ICD-9 and ICD-10 
codes. With the exception of codes for hearing care procedures, 
we only used diagnostic codes assigned before the HA order; 
thus, all were coded using the ICD-9 code set. For hearing care 
procedures, we used both ICD-9 and ICD-10 codes so we could 
examine hearing care both before and after the HA order.
To examine how multiple chronic conditions impact a 
patient’s hearing health outcomes, we created a multimorbidity 
index using the Chronic Condition Indicator (Healthcare Cost 
and Utilization Project 2016). For each ICD-9 code, the Chronic 
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Condition Indicator indicates (1) whether the code pertains to a 
chronic condition or not and (2) to which of 18 body systems it 
belongs. The number of body systems for which a patient has at 
least one diagnostic code for a chronic condition is then totaled. 
Note that every patient in our dataset should have a code in 
body system 6 (“Nervous system/sense organs”) associated 
with their hearing loss. Therefore, in order that the multimor-
bidity index remains sensitive to codes for all other chronic 
conditions in body system 6, we computed the index following 
removal of hearing-loss related codes in ICD-9 code group 389.
XX. The resultant multimorbidity index can range from 0 to 
18. To enable a direct comparison with data from Zulman et al. 
(2015) (see “Disease Burden” section later), the time window 
used for applying diagnostic codes to the multimorbidity index 
was the 12 months before HA order for each individual patient, 
and a body system was only included in the count if the patient 
had at least two diagnostic codes pertaining to that system.
RESULTS
The results presented here include descriptive analyses of the 
dataset, along with comparative analyses for assessment of the 
internal and external validity of the data, and bivariate analyses 
that illustrate the potential of the dataset to reveal significant 
and novel associations between demographic and general health 
variables and long-term HA use persistence.
As a brief reminder, the study sample is composed of VA 
patients who had a HA order between April 1, 2012, and October 
31, 2014. For these patients, the following data were extracted: 
(1) audiometric data and HA information from April 1, 2012, 
to October 31, 2014; (2) battery orders from April 1, 2012, to 
December 31, 2017; (3) IOI-HA self-report data up to 180 days 
beyond each individual’s HA fitting date; and (4) demographic 
information, ICD, and procedural codes from January 1, 2007, 
to December 31, 2017.
Of the total sample of 731,213 patients with a HA order, 
99.8% (n = 730,107) had one or more battery orders between 
April 1, 2012, and December 31, 2017, 21.7% (n = 158,684) 
had one or more sets of IOI-HA responses, 78.6% (n = 574,896) 
had air conduction audiogram data, and 18.6% (n = 136,341) 
had all of the above.
For a given patient, a HA order could occur at any time 
within the 31-month period from April 2012 to October 2014, 
but postorder data were extracted to December 31, 2017. Thus, 
the time period for which data are available after the HA order 
varies from patient to patient, from a minimum of 38 months 
(patients with a HA order at the end of October 2014) to a maxi-
mum of 69 months (patients with a HA order at the start of April 
2012). In order that all patients are equitably represented in our 
analyses, we used a time period of 38 months post-HA order 
when applicable and included only those patients who survived 
throughout the time period in question.
Data Descriptives
Patient Demographics • Of the 731,213 patients with a HA 
order, 53% and 47% were defined by ROES as being new HA 
recipients and experienced HA users, respectively. As noted 
earlier, an experienced user is a patient with a prior HA order 
in ROES.
The age range of the study sample was 20 to 90+ years. 
The mean age of the new recipients was 70.6 years (SD: 11.7 
years) and of the experienced users was 75.7 years (SD: 11.0 
years). The age distributions were not unimodal (see File 5 in 
Supplemental Digital Content 5, http://links.lww.com/EANDH/
A736 for histograms of age at date of first HA order). Their 
shape reflects a combination of the onset of age-related hearing 
loss, variations in the number of U.S. Veterans over time, the 
age at which patients chose to acquire HAs, and changes in VA 
HA eligibility policies.
The vast majority (98.4%) of patients were male. The gen-
der distribution was somewhat age-dependent, with 93.9% of 
the sample <60 years old being male, and 98.9% 60+ years old 
being male. A similar pattern of results is seen in the National 
Center for Veterans Analysis and Statistics Table 1L (https://
www.va.gov/vetdata/veteran_population.asp), which docu-
ments that in 2015, 85.0% of Veterans under age 60 years were 
male, and 96.0% over age 60 years were male.
Hearing-Care Processes • A total of 9,210,309 hearing-
related encounters were identified between 2007 and 2017. 
Overall, 53.5% were for HA-related activity only, 4.3% were for 
audiometry-related activity only, and 13.7% were for audiome-
try and HA activity combined. The remaining 28.5% of encoun-
ters were for other hearing-related issues, including tinnitus. On 
average, patients had 1.9 hearing-related encounters each year.
A valid audiogram was available for 570,295 patients (78.0%). 
To understand the timing of audiometry relative to HA orders, we 
examined patients with one valid audiogram and one HA order (n 
= 469,396). Most of these patients had a HA order immediately, 
or shortly after, an audiometric evaluation. Specifically, 67% of 
patients had a HA order on the same day as the evaluation, 14% 
had a HA order within 2 weeks, and 16% had a HA order between 
2 weeks and 6 months after the audiometric evaluation.
Audiometry • Among all patients with valid audiograms 
(n = 570,295), average 4F-PTAs were 49.9 dB (SD: 16.8 dB) and 
48.7 dB (SD: 17.1 dB) for the left and right ears, respectively. 
A t test shows this to be a statistically significant difference 
(t = 67.6; p < 0.001). To further examine the pattern of asymme-
tries, we looked at the direction of asymmetry among the 14.6% 
of patients with a clinically relevant asymmetry. Of these, 57.7% 
had a greater hearing loss in the left ear (χ2 = 1969.7; p < 0.001). 
As seen from Figure 2, this left ear asymmetry is most evident 
at higher frequencies. A left ear asymmetry is not uncommon in 
the military (Job et al. 1998), and while a proportion of patients 
are likely to be left-handed, we believe the asymmetry is prob-
ably due to the impact of shooting, in which the ear closest to 
the barrel of the gun (left ear for right-handed shooters) tends to 
be worse because it is closer to the explosion, whereas the other 
ear is protected by the head (Yong & Wang 2015).
HA Orders • Table  2 shows information about the number, 
style, and laterality of HA orders. The vast majority of patients 
had one order for bilateral HAs, with almost half being for 
receiver in the canal devices. Within our study time window, a 
single HA order is to be expected, since VHA Handbook 1173.7 
(Department of Veterans Affairs 2000) states that Veterans’ HAs 
“will be replaced when the instrument proves to be ineffective, 
irreparable, or the Veteran’s medical condition has changed and 
a different device is needed” which will rarely occur within the 
first 31 months (the longest time period for which we have HA 
order data for any patient). Additional HA orders are possible 
because sometimes HAs for the left and right ears are ordered 
separately, and because the VA permits an additional order if 
HAs are lost or destroyed “due to circumstances beyond the 
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control of the Veteran,” or because the patient has severe enough 
hearing loss to warrant the issuance of spare HAs. This likely 
explains why 2% of patients had two or more HA orders. The 
distribution of HA styles here is comparable to that of the U.S. 
private sector during the same time period, where receiver in the 
canal, in the ears, and behind the ears represented 54%, 25%, 
and 21% of the market, respectively (Strom 2013).
Battery Orders • Practically all patients had at least one 
battery order after their first HA order; just 1785 individu-
als (0.24%) had none. In total, 2,806,742 battery orders were 
placed on or after the date of a patient’s first HA order. Figure 3 
illustrates that the number of battery orders placed during the 
38-month period varied widely across patients (range: 0 to 21; 
mean: 3.2, SD: 2.0, median: 3).
Figure 4 shows the distribution of times between the HA order 
and the first battery order. The mean was 42 days (SD: 46.6 days), 
the median was 34 days. Based on our use of the first battery order 
as a proxy for the HA fitting date, we can say that on average, the 
HA fitting took place 42 days after the HA was ordered. The time 
between subsequent battery orders ranged from <1 month to 30 
months (median: 7.8 months, mean: 9.5 months). This time is 
consistent with the 6-month period that a battery order is pro-
jected to last and perhaps indicates that patients typically use their 
HAs for two thirds of the time rather than fulltime.
When data are examined for individual patients, some show 
both long and short intervals between battery orders, perhaps 
suggesting variability in HA use over time.
Fig. 2. Distribution of left (black bars) and right (white bars) thresholds at 0.5 to 8.0 kHz. Gray bars indicate areas of overlap between ears. When patients had 
multiple audiograms, average thresholds across audiograms were used. Dashed outlines for bars at 120 dB HL denote that the value was assigned in the data 
cleaning/preparation process (see File 3 in Supplemental Digital Content 3, http://links.lww.com/EANDH/A734).
TABLE 2. Characteristics of hearing aid orders in the study 
sample
Characteristic No. patients Percent (%)
No. hearing aid orders
 1 715,237 97.8
 2 15,432 2.1
 >2 544 0.07
Laterality of fitting
 Bilateral 680,814 91.0
 Unilateral, left ear 36,602 4.9
 Unilateral, right ear 30,352 4.1
Hearing aid style
 BTE 197,065 26.4
 ITE* 224,081 30.0
 RIC 326,622 43.7
*ITE includes all custom hearing aid styles.
BTE, behind the ear; ITE, in the ear; RIC, receiver in the canal.





















Fig. 3. Distribution of the number of battery orders in the 38 mo following the 
first HA order for the 612,679 patients with a single HA order who survived 
at least 38 mo following the HA fitting. Data for the 0.26% of patients who 
had >10 HA orders are omitted from the figure. HA indicates hearing aid.
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HA Use Persistence • As previously described, the persistence 
of HA use was computed from the battery order data. The mean 
persistence at 24 months after the HA fitting for patients who 
survived for at least this time was 63.3%.
Figure  5 compares this persistence value to therapy per-
sistence for 13 other chronic conditions using data from three 
systematic reviews (Yeaw et al. 2009; Hichborn et al. 2018; 
Menditto et al. 2018). Persistence in our dataset was higher 
than for all other conditions, despite our value being calcu-
lated at 24 months, while the data for the other conditions is 
at 12 months. It is clear that relative to medications for many 
other chronic conditions, persistence for HA use in our sample 
is high.
Self-Reported Outcome: IOI-HA • IOI-HA data were avail-
able for 20.1% (n = 146,699) of patients. This relatively low 
figure is likely due to three factors, each of which plays an inde-
pendent role. First, the ROES data entry system only allows for 
entry of complete IOI-HAs, so questionnaires returned with 
missing data cannot be entered. Second, administration of the 
IOI-HA is recommended but is not mandatory; thus, other mea-
sures, or no measures, might have been used. Third, IOI-HA 
data are dependent upon patients returning the questionnaire, 
which does not always happen. We cannot determine the extent 
to which each of these explanations applies.
Of the available  IOI-HA surveys, 15.7% were returned 
within 14 to 30 days after the fitting, 54.0% were returned 
between 31 and 60 days, 25.9% between 61 and 120 days, 
and 4.5% between 121 and 180 days. Altogether, 13.8% were 
returned on a day for which we could also identify a HA-related 
appointment, suggesting that they were either completed at the 
appointment or returned by hand to the audiologist.
IOI-HA scores were generally high (mean: 28.8, SD: 4.1 on 
a scale of 7 to 35), with 64.7% of patients having a score ≥28, 
indicating that on average, they gave a rating of four or more on 
all seven questions. Only 4.5% of scores were ≤21, indicating 
average ratings of three or less on all items.
Data Validity
To assess the validity of our data, we conducted analyses to 
examine whether expected relations between variables existed 
and made comparisons of the data here with other published 
data, as follows.
Representativeness of IOI-HA Data • Given that valid 
IOI-HA surveys were available for only 20.1% of patients, it 
is important to assess whether individuals with IOI-HA data 
























2 4 6 8 12 14
Fig. 4. Distribution of time between the HA order and first battery order for 
the 612,679 patients with a single HA order who survived at least 38 mo 
following the HA fitting. HA indicates hearing aid.
Fig. 5. Persistence at 12 mo (%) to medications for listed conditions, along with persistence at 24 mo postfitting for hearing-aid use from this study. COPD 
indicates chronic obstructive pulmonary disease; HIV, human immunodeficiency virus.
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differ from the rest of the study population. Welch two-sample 
t tests were used to compare age, hearing loss, and number of 
battery orders for patients with and without IOI-HA data, and 
Chi-square analysis was used to compare the proportions of 
new HA recipients and experienced HA users with and with-
out IOI-HA data. The results are shown in Table 3. Relative to 
patients without IOI-HA data, those with IOI-HA data were 
on average 1.5 years older, had marginally better hearing, 
and ordered more HA batteries, and a higher proportion were 
new HA recipients. While the comparisons show statistically 
significant differences, the actual group mean differences are 
very small and likely do not demonstrate clinically meaningful 
differences.
The IOI-HA scores here are slightly higher than those found 
in other published studies for Veterans (Smith et al. 2009) and 
non-Veterans (Hickson et al. 2010; Arlinger et al. 2017) alike. 
Relative to Smith et al. (2009), the higher scores here might 
be associated with the improvement in technology over time. 
Relative to Arlinger et al. (2017) and Hickson et al. (2010), this 
might be because the Veterans here received HAs free of charge, 
while only a proportion did in the Arlinger et al. (2017) and 
Hickson et al. (2010) datasets. Indeed, many publications and 
surveys indicate that, for whatever reason, Veterans are gener-
ally more satisfied with the care they receive than are private 
care patients (O’Hanlon et al. 2017; Anhang Price et al. 2018).
Audiometric Sensitivity and Self-Reported Hearing 
Difficulty • Published literature (e.g., Choi et al. 2016; Kim 
et al. 2017) shows a moderate association between audiometric 
sensitivity and self-reported hearing difficulties, we thus expect 
the same to hold here. To examine this, we used a violin plot to 
show the association between 4F-PTA and IOI-HA question 8 
(Fig. 6). It illustrates that self-reported hearing loss increases as 
the 4F-PTA increases (Pearson r value: 0.41), but that there is 
considerable variability.
About 1% of respondents perceived no hearing difficulties 
despite many having moderate hearing loss or greater. Some of 
these individuals might have inadvertently responded to item 8 
of the IOI-HA with respect to aided (rather than unaided) lis-
tening, they may have obtained HAs at the request of a fam-
ily member, or they may have been confused by the IOI-HA 
response form. The data here do not allow us to disentangle 
these potential explanations.
Joint Distribution of Age and PTA • Table 4 compares the 
age versus PTA distribution in our sample with those reported 
by Aronoff et al. (2010) for 48,561 HA users who obtained 
HAs in the private sector. Regarding the overall age distribu-
tion, we see a similar proportion of individuals age <60 years in 
both samples, but our sample shows more young-old (60 to 69 
years) and fewer old-old (80+ years). Among those <70 years 
old, our sample shows a much larger proportion of HA users 
with relatively mild losses. Apart from these differences, the age 
versus PTA distributions are fairly similar between the samples, 
reflecting age-related trends in PTA.
The observed differences may reflect the source of payment 
(i.e., self-pay versus VA subsidy), as well as higher rates of HA 
uptake resulting from conditions associated with mild traumatic 
brain injury (tinnitus and central auditory processing disorders) 
for which HAs are being recommended in Veterans.
Disease Burden • Figure 7 is a histogram of multimorbid-
ity index scores at the time of the HA order. Scores ranged 
from 0 to 13 (mean: 2.72). Zulman et al. (2015) used the 
same tool to compute a multimorbidity index and reported 
scores for a subset of 261,699 Veterans considered “high 
cost” to VA, as well as for the remaining 95% of their large 
sample of Veterans. Among the “high cost” group by Zulman 
et al. (2015), 64% had ≥3 body systems affected by chronic 
conditions, and 18% had ≥5 body systems affected, while 
in the remainder of their sample, the corresponding values 
were 19% and 2%, respectively. In our sample, we observe 
51% with ≥3 body systems affected by chronic conditions, 
and 20% with ≥5 body systems affected. At first glance, this 
appears to suggest that our sample was composed of patients 
with relatively high levels of multimorbidity. However, we 
cannot fully replicate the filtering of diagnostic counts used 
by Zulman et al. (2015) because of their scant reporting. As a 
result, the comparison with Zulman et al. (2015) neither sup-
ports nor refutes the external validity of our data. Regardless 
of this, we believe that the calculation of multimorbidity is 
valuable, both with respect to internal validity (as patients 
demonstrate a wide range of values) and as a robust indicator 
of disease burden which as seen later, provides insights into 
predictor variables and outcomes.
TABLE 3. Representativeness of IOI-HA data
Characteristic
With IOI data, 
 mean (SD)
Without IOI data, 
mean (SD)
Results of between-group  
comparisons, t/χ2 (df); p
Age (yr) 74.3 (10.3) 72.8 (11.9) t = –48.5 (253,610); p < .001
4F-PTA (dB HL) 49.2 (14.8) 49.3 (15.7) t = 3.32 (212,800); p < .001
Battery orders (over 38 mo) 3.5 (2.05) 3.1 (2.0) t = –71.2 (199,560); p < .001
% New HA recipients 55.3 51.5  χ2 = 657.93 (1); p < .001






























Fig. 6. Violin plot of 4F-PTA (y axis) by responses to IOI-HA question 8 
self-reported difficulty (x axis). Values indicate percentage of responses 
within each category. Horizontal lines indicate hearing loss severity as 
defined in Martin (1986). 4F-PTA indicates four-frequency pure-tone aver-
age, IOI-HA, International Outcome Inventory for Hearing Aids.
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Illustrative Associations Between Predictors and HA 
Outcome
The dataset allows examination of associations between 
predictor variables (general health, demographics, audiometry) 
and HA outcomes. Of the many possible such analyses, we here 
present those that emphasize novel associations and that focus 
on our measure of persistence for long-term HA use.
Certain chronic conditions are comorbid with hearing 
loss and/or auditory processing difficulties or have been sug-
gested as conditions that may make HA use more challeng-
ing. Figure  8 shows associations between the presence of 
Parkinson’s disease (ICD-9-CM 332.0 and 332.1), diabetes 
(ICD-9-CM 250), arthritis (ICD-9-CM 360-379), and vision 
impairment (ICD-9-CM 710-739) at the time of the HA order 
and HA use persistence. Patients are separated by whether or 
not they had each of the four chronic conditions of interest and 
by age group. Figure 8 illustrates that patients with each con-
dition had lower HA use persistence relative to those without 
the condition.
To examine how general disease burden impacted HA use 
persistence, Figure 9 shows persistence plotted against multi-
morbidity index score and age group, and Figure 10 shows HA 
use persistence for people with and without an inpatient hospi-
talization event before their HA order. From Figure 9, it is seen 
that persistence was lower for new HA recipients than experi-
enced HA users, and lower for patients 60 to 69 years old than 
for older patients. Further, persistence decreased with increas-
ing disease burden (higher multimorbidity index score), and 
disease burden impacted new HA recipients to a greater extent 
than experienced users, as illustrated by the steeper downward 
slopes in the former group.
Figure 10 shows similar results, with the impact of an inpa-
tient hospitalization being greater for patients over age 70 years 
than for those younger than 70 years and being greater for new 
HA recipients than for experienced users. HA use persistence 
decreases slightly among the very old patients (age 90+ years). 
This may be explained by other variables not accounted for in 
these simple analyses and points to the value of multivariate 
approaches for in-depth understanding.
GENERAL DISCUSSION
We have described the extraction, content, and data clean-
ing processes for data from a large number of patients who 
had received HAs from VHA within a 31-month time window. 
We also present findings that illustrate data validity and pro-
vide some examples of how the data can be used in audiologi-
cal research. We consider that the findings can be applied to 
the population as a whole because while Veterans have higher 
prevalence of some chronic conditions relative to the general 
population, the behavioral and medical factors that cause these 
conditions are present in both, as are the mechanisms that con-
nect conditions to hearing health and persistence of HA use.
Data cleaning and preparation involved multiple steps and 
processes. As further discussed in Dillard et al. (2020), these 
were completed to avoid biases that can arise when using 
EHRs for research (Verheij et al. 2018). These processes, com-
bined with examination of internal and external validity, give 
us confidence in the integrity of the data. For example, we 
determined that
1) Application of audiological expertise (e.g., awareness 
that testing is conducted in 5 dB HL steps, interpreting 
“DNT/CNT,” (Did not test/Could not test),  familiarity 
with the upper limit threshold of audiometers) allowed 
us to address anomalies associated with audiometric 
data.
2) Mean ages and 4F-PTAs of our sample (e.g., Aronoff et al. 
2010; Abrams and Kihm 2015; Simpson et al. 2019) and 
mean IOI-HA scores (Smith et al. 2009; Arlinger et al. 
2017) are similar to those found in other studies, as is the 
moderate correlation between measured and self-reported 
hearing loss (Choi et al. 2016; Kim et al. 2017).
We had to designate a proxy variable for the date of the HA 
fitting because the dataset did not include a specific CPT code 
TABLE 4. Comparison of age vs. PTA distributions
Source
PTA* (dB HL)
<25 25–44 45–54 55–64 65–84 >84
Aronoff et al. (2010)
 % of total  
sample† Age (yr) % within age band
  12 25–59 2 30 25 19 17 7
  17 60–69 1 27 26 20 20 5
  28 70–79 0 21 29 27 21 3
  40 80–94 0 8 24 34 30 4
Our sample
 % of total  
sample† Age (yr) % within age band
  10 25–59 14 58 17 7 4 1
  33 60–69 3 44 29 15 8 1
  25 70–79 1 26 31 24 16 3
  31 80–94 0 9 24 32 30 5
*PTA is here calculated as mean of 0.5, 1, 2, 3, 4 kHz, consistent with Aronoff et al. (2010).
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Fig. 7. Distribution of multimorbidity index scores calculated at HA order 
date using a revised version of the Chronic Condition Indicator (Healthcare 
Cost and Utilization Project 2016) in which hearing-loss related codes in 
body system 6 (nervous system/sense organs) were omitted. Data for 0.06% 
of patients with multimorbidity scores of 11 to 13 are omitted from the 
figure. HA indicates hearing aid.
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for this. There were two reasonable options for a proxy HA fit-
ting date—the date of the first battery order or the date of the 
first hearing care event after the HAs were ordered. We chose to 
use the first battery order date because 99.8% of patients had at 
least one valid battery order, while only 93.5% of patients had 
an identifiable hearing care event after the HA order. The latter 
is probably due to codes being assigned that were not in our 
hearing care code list (File 2 in Supplemental Digital Content 
2, http://links.lww.com/EANDH/A733) or to instances in which 
the fitting was not assigned a code in the EHR. Further, 22.6% 
of patients had a first battery order date before the first hearing 
care appointment after the HA order. It seems improbable that 
batteries were ordered before the HA fitting, thus suggesting 
that the first hearing care appointment after the HA order is not 
always a good proxy for the HA fitting date. It is worth noting, 
however, that the distributions of the first HA order and the first 
hearing care event after the HA order are similar, they are just 
shifted slightly in time.
The presence of battery ordering data in our dataset provided 
a unique opportunity to derive a measure of ongoing HA use 
out to much later durations than are typically captured. Prior 
studies of long-term HA use are limited in population size and/
Fig. 8. Mean HA use persistence (y axis) by age group (x axis) for individuals with (asterisk) and without (open circle) diagnostic codes assigned before the HA 
order indicating the presence of PD, diabetes, arthritis, and visual impairment. Data points omitted for patient groups where n < 200. HA indicates hearing 
aid; PD, Parkinson’s disease.






























Fig. 9. Mean HA use persistence (y axis) by multimorbidity index score (x axis) for individuals 60–69 yr (filled circle), 70–79 yr (asterisk), and 80–89 yr old 
(open triangle) for new HA recipients and experienced HA users separately. Data points omitted for patient groups where n < 200. HA indicates hearing aid.
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or duration (e.g., Gianopoulos et al. 2002; Humes et al. 2002; 
Doyle et al. 2018). We used battery order information over time 
to compute HA use persistence at 24 months postfitting. While 
we acknowledge that this variable has limitations, such as the 
measure being coarse because battery orders are calibrated to 
last 6 months and the likelihood that some patients obtained 
HA batteries from outside of the VA, it nonetheless provides 
insights into long-term HA usage (up to 5 years) for a very large 
sample of patients, including plausible dependencies on age, 
user type, comorbidities, etc., as reported here.
A third variable that should be interpreted with some caution 
is the ROES-designated variable for HA user experience. As 
already noted, the ROES system labels anyone receiving their 
first pair of HAs from the VA as a new HA recipient. It is likely 
that a proportion of individuals designated as new recipients 
had acquired HAs in the past from a non-VA source. However, 
we consider the impact of this to be negligible. If anything, such 
mislabeling will cause outcome differences between new HA 
recipients and experienced HA users to be underestimated.
Missing data can cause biases that must be considered 
when interpreting findings. Of the 731,213 patients with 
a HA order, 21.4% had no audiometric data in the system, 
even though all must have had an audiometric examination 
at some point. We speculate this is either because data were 
not entered into the Hearing Loss Repository because this 
was not required before 2015 or because data were entered 
before our study time window. However, there is no reason 
to believe that such effects would result in a systematic dif-
ference between those with and without audiometric data; 
thus, we are not concerned about a systematic bias here. 
Similarly, IOI-HA data were missing for 80% of patients. As 
noted earlier, the reasons for this are likely to be a combina-
tion of patient response behaviors and administrative issues. 
Although there were statistically significant audiometric and 
demographic differences between individuals who had and 
did not have IOI-HA data, the differences are very small in 
magnitude and not clinically relevant, so the potential bias is 
unlikely to impact on the outcome of our analyses.
Not all medical history is captured in the VA EHR, as 
some individuals choose to seek medical care from outside 
of VA, some services are only provided to individuals quali-
fying for those services, and many Veterans have second-
ary health care coverage (Liu et al. 2011). However, there 
is no reason to expect that these differences are systematic. 
Further, as discussed in Dillard et al. (2020), we attempted 
to capture all relevant conditions by using multiple codes 
(as opposed to one) to classify particular diagnoses and by 
broadening coding categories to account for changes in cod-
ing practices over time.
Our findings of decreased HA use persistence in the pres-
ence of chronic conditions, and that the effect is greater among 
patients over age 70 years, and in new HA recipients, are plau-
sible for at least two reasons. First, primary care practitioners 
and patients alike deprioritize hearing loss management in favor 
of other chronic conditions (Sidorkiewicz et al. 2019). Second, 
some chronic conditions may limit a patient’s physical ability to 
manage HAs. Specifically, vision loss leads to problems seeing 
small low contrast HA components, arthritis, and Parkinson’s 
disease impair the ability to steadily hold, insert, clean, and 
adjust HAs, while diabetic peripheral neuropathy and retinopa-
thy lead to changes in sensitivity of the fingertips and to vision 
loss, respectively. Our findings for these specific conditions are 
consistent with such explanations.
The finding that these associations are stronger among older 
individuals could be due to the combination of disease sever-
ity and cognitive aging. Unfortunately, data regarding disease 
severity are unavailable from CPT codes.
There are, of course, limitations to using clinical data for 
research. First, clinical data are not collected or recorded in the 
same controlled manner as in prospective research. As a result, 
the data require cleaning and careful interpretation. Nonetheless, 






















































Fig. 10. Mean HA use persistence (y axis) by age group (x axis) for individuals with (asterisk) and without (open circle) a procedural code indicating an inpa-
tient admission before the HA order for new HA recipients and experienced HA users separately. Data points omitted for patient groups where n < 200. HA 
indicates hearing aid.
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a multitude of variables outweigh these disadvantages. The data 
in this particular dataset do not allow us to identify factors that 
led to the HA order, nor about the audiological pathways of 
those who did not receive HAs. In particular, we cannot deter-
mine whether some comorbid conditions prevent or impede the 
likelihood of a HA order in the first place. This will affect any 
estimation of the difficulties that the comorbid conditions pres-
ent for HA usage and outcome.
In principle, the dataset does not permit firm conclusions 
regarding causal relationships between predictor variables and 
treatment outcomes. However, when consistent associations 
are found between diverse comorbidities and HA use persis-
tence, and in the absence of plausible mechanisms to explain 
how HA use/disuse might affect these comorbid conditions, we 
are likely to conclude that HA use/disuse is the effect rather 
than the cause. Further multivariate modeling and consideration 
of interactions will allow deeper examination of associations 
between prefitting health state and postfitting outcomes and 
may indicate whether all associations are, in fact, the result of 
a common cause. In addition, where plausible hypotheses can 
be formulated, the quasi-longitudinal nature of the dataset will 
allow analyses of the impact of long-term HA use on health 
states postfitting.
In sum, despite these limitations, the findings have both sci-
entific and clinical application. The availability of information 
about other health conditions in combination with audiological 
and long-term HA use data is relatively rare and allows us to 
consider multiple factors associated with hearing loss and HA 
usage. Even with these preliminary analyses, we have learned 
much about important associations between chronic diseases, 
disease burden, and HA outcome. While it has often been sug-
gested that certain chronic diseases and disease burden will 
impact HA use, these findings have not been empirically illus-
trated before. Such findings could ultimately be applied to ser-
vice planning in the same manner as did Swan et al. (2017) 
using VA chart records of Veterans with hearing loss and other 
post-deployment conditions. In addition, the use of clinical 
datasets such as this one facilitates the use of new methodolo-
gies in audiological research, such as machine learning and pre-
dictive modeling (Saunders et al. 2020).
Indeed, we plan to conduct further analyses of the data 
with a view to generating new hypotheses that could be tested 
prospectively using future data extracted from the same 
sources. This could shed light on aspects of HA outcome 
associated with changing hearing device technology, impacts 
of comorbid conditions including cognition, and changing 
VA practices such as telemedicine. This dataset positions us 
to investigate relationships of HA use, health, and additional 
outcome data.
SUMMARY AND CONCLUSIONS
Research utilizing EHRs in audiology has the potential to 
provide novel insights into clinical practice patterns, audiologic 
outcomes, and relations between factors pertaining to hearing 
and to other health conditions in clinical populations. However, 
until now, large-scale data projects in the field of audiology 
have been rare. Here, we have described a large dataset of indi-
viduals fit with HAs in the VA system and presented findings 
related to internal and external data validity as well as associa-
tions between HA outcomes and other health conditions, which 
we believe would generalize beyond the Veteran population. 
The article also provides other researchers with a framework 
for working with EHRs and demonstrates the importance of 
understanding the source, integrity, and validity of the data in 
the EHR system. Despite the relatively uncontrolled and diverse 
circumstances under which the data were generated, the large 
size of the dataset means that the gross patterns of relations 
among primary variables look much as one would expect on the 
basis of previous literature. This suggests that the data possess 
acceptable validity to carry further detailed analyses. Based on 
this, and considering the various caveats provided, we conclude 
that research using EHRs has the potential to be an integral 
supplement to population-based and epidemiologic research in 
the field of audiology.
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